A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CR / clinical response

[Related PubMed/MEDLINE]
Total Number of Papers: 49
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CR  (>> Co-occurring Abbreviation)
Long Form:   clinical response
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Colistin monotherapy versus colistin/rifampicin combination therapy in pneumonia caused by colistin-resistant Acinetobacter baumannii: A randomised controlled trial. CoRAB, MR
2019 Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies. CD, CDAI, HBI, PRO
2019 Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis. CV, CZP, ETN, FMD, IMT, PWV, RA, TNF, vNR, VR
2019 Indigo naturalis is effective even in treatment-refractory patients with ulcerative colitis: a post hoc analysis from the INDIGO study. FCP, IM, IN, MH, UC
2019 Long-Term Survival and Complete Response to Anastrozole in Breast Cancer Patient With Cutaneous Metastases Only. BC, MBC
2019 The VALID-CRT risk score reliably predicts response and outcome of cardiac resynchronization therapy in a real-world population. CI, CRT, HF, HR, MORE, pts
2018 Unexpected and durable response with regorafenib in a metastatic colorectal cancer patient without KDR mutation: A case report. CRC, KDR
2016 Early effect of dalfampridine in patients with MS: A multi-instrumental approach to better investigate responsiveness. 4-AP, AMP, TBSS
2016 Imaging strategy for response evaluation to chemoradiotherapy of the nodal disease in patients with head and neck squamous cell carcinoma. CRT, CT, FDG-PET, MRI
10  2015 Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders. LN, NRs, PR
11  2015 Evaluation of B lymphocyte stimulator and a proliferation inducing ligand as candidate biomarkers in lupus nephritis based on clinical and histopathological outcome following induction therapy. BLyS, HR, LN, PLN, SLE
12  2015 Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis. AEs, AIs, BC, CI, HR, SNPs, TTP
13  2015 [Efficacy and safety of topical PUVA treatment for refractory lesions of mycosis fungoides]. PR
14  2014 Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer. CRT, PI, SCC
15  2014 Palliative local radiotherapy in the treatment of tumor-stage cutaneous T-cell lymphoma/mycosis fungoides. MF, PR
16  2014 Plasma vascular endothelial growth factor 165 in advanced non-small cell lung cancer. NSCLC, OS, PFS, VEGF165
17  2014 [Clinical experience of imatinib mesylate for metastatic or recurrent gastrointestinal stromal tumor]. GIST, PD, PR, RECIST, SD
18  2013 Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis. CD, ICER, MH, QALY
19  2013 Detection of disseminated tumor cells in locally advanced breast cancer patients before primary systemic therapy. DFS, DTC, LABC, OS, PST
20  2013 Early stage W.H.O. grade I and II follicular lymphoma treated with radiation therapy alone. FL, FLIPI, OS, PFS, RT
21  2013 [Clinical outcome of treatment with infliximab in Crohn's disease: a single-center experience]. CD, IFX
22  2012 Correlation in rectal cancer between clinical tumor response after neoadjuvant radiotherapy and sphincter or organ preservation: 10-year results of the Lyon R 96-02 randomized trial. CRPC, EBRT
23  2012 Increased documented brief alcohol interventions with a performance measure and electronic decision support. BIs, PM, VA
24  2009 Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy. cNR, CSS, MIBC, RC, TURB
25  2009 Photodynamic therapy using methyl aminolevulinate in the management of primary superficial basal cell carcinoma: clinical and health economic outcomes. BCC, CO, RCTs, sBCC
26  2008 Evaluation of antibiotic sensitivity pattern in cases of enteric fever in north west Rajasthan. ---
27  2008 Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy. CRC, ERCC1, OS, OX, PFS, XPD
28  2008 [A case of paclitaxel and trastuzumab-resistant recurrent breast cancer with liver metastasis responding to S-1]. ---
29  2007 Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma. DFS, PET
30  2006 Comparison of probability of target attainment calculated by Monte Carlo simulation with meropenem clinical and microbiological response for the treatment of complicated skin and skin structure infections. CFR, MIC, MR
31  2005 Prognostic significance of a combined clinicopathologic score for response to primary systemic therapy in locally advanced breast cancer. cpR, LABC, PR
32  2005 Tumour localisation with a metal coil before the administration of neo-adjuvant chemotherapy. NAC, pCR, rCR
33  2004 Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer. CRT, PR
34  2004 Timing isn't everything: an analysis of when to start salvage chemotherapy in ovarian cancer. CT, PFS, pts
35  2004 Transvaginal color Doppler sonography for predicting response to concurrent chemoradiotherapy for locally advanced cervical carcinoma. PI, PR, PSV, RI, TVCD
36  2002 Photodynamic therapy for the treatment of extramammary Paget's disease. ALA, EMPD, PDT
37  2002 The impact of TNF-alpha induction on therapeutic efficacy following high dose spatially fractionated (GRID) radiation. ELISA, PR
38  2000 Chemotherapy for malignant mixed Mullerian tumors of the ovary. MMMT, PC, PI
39  2000 Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States. MC
40  1999 Lessons from the use of aromatase inhibitors in the neoadjuvant setting. CI
41  1999 Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer. PR
42  1999 Relapse after complete response to anthracycline-based combination chemotherapy in metastatic breast cancer. DFI, MBC
43  1997 5-Fluorouracil, interferon-alpha-2b and cisplatin (FAP) for advanced urothelial cancer. A phase II study. Hellenic Co-operative Oncology Group. FAP, PR
44  1997 Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer. PR
45  1994 Pilot study of sequential combination chemotherapy in advanced and recurrent retinoblastoma. ---
46  1994 Significant activity of paclitaxel in advanced transitional-cell carcinoma of the urothelium: a phase II trial of the Eastern Cooperative Oncology Group. CI, PR, rhG-CSF
47  1994 Treatment of primary fallopian tube carcinoma with cisplatin-containing chemotherapy. CAP, pCR, PD, PR, SLO
48  1987 Improved response and survival to combined cisplatin and radiation in non-keratinizing squamous cell carcinomas of the head and neck. An RTOG study of 114 advanced stage tumors. ALL, REST, RTOG, SCC
49  1986 [Treatment results of carcinoma of the lower gum with radiation therapy combined with bleomycin]. ---